Bandaram Pharma Packtech Ltd.
BSE: 524602
₹28.70
₹0.70
(2.50%)
As on 16-Jun-2026IST
Market cap
₹52 Cr
Revenue (TTM)
₹63 Cr
P/E Ratio
115.1
P/B Ratio
1.9
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹0 Cr
-
ROE
8 %
-
ROCE
8.4 %
-
Industry P/E
21.27
-
EV/EBITDA
25.6
-
Debt to Equity
0.4
-
Book Value
₹14
-
EPS
₹0.2
-
Face value
10
-
Shares outstanding
17,971,920
10 Years Aggregate
CFO
₹-9.62 Cr
EBITDA
₹4.50 Cr
Net Profit
₹-0.14 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Bandaram Pharma
| -3.6 | 1.9 | -1.0 | -21.1 | 2.5 | -- | -- |
|
BSE Commodities
| 6.6 | -1.3 | 12.4 | 11.7 | 15.6 | 10.1 | 15.4 |
|
Company
|
2025
|
2024
|
|---|---|---|
|
Bandaram Pharma
| -34.7 | 48.8 |
|
BSE Small Cap
| -6.6 | 29.0 |
|
BSE Commodities
| 12.5 | 8.1 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Bandaram Pharma
|
28.7 | 51.6 | 62.9 | 0.5 | 3.6 | 1.7 | 115.1 | 1.9 |
| 62.8 | 1,259.7 | 1,701.2 | 18.6 | -2.4 | 1 | 67.7 | 0.6 | |
| 1,315.7 | 14,688.5 | 407.2 | -101.7 | -104.8 | -8.4 | -- | 4.0 | |
| 357.1 | 6,449.5 | 7,151.6 | 281.0 | 7.7 | 5.2 | 24.3 | 1.2 | |
| 81.7 | 782.4 | 807.9 | 93.6 | 13.4 | 14.4 | 8.4 | 1.2 | |
| 221.0 | 1,388.5 | 1,710.5 | 82.5 | 3.0 | 4.1 | 16.8 | 0.7 | |
| 155.4 | 2,549.7 | 2.0 | -0.3 | -16.9 | -0.3 | 34.2 | 7.6 | |
| 10.0 | 1,164.3 | 1,069.1 | 102.5 | 9.0 | 35 | 11.4 | 3.5 | |
| 144.8 | 1,000.8 | 4,644.9 | 247.8 | 3.6 | 11.3 | 4 | 0.4 | |
| 514.6 | 3,400.5 | 4,292.8 | 155.7 | 3.8 | 4.2 | 22.6 | 0.9 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Bandaram Pharma
Shiva Medicare Limited does not have significant operations. The company was incorporated in 1991 and is based in Hyderabad, India.
-
Incorporated
1993
-
Chairman
B Deepak Reddy
-
Managing Director
B Deepak Reddy
-
Headquarters
Bengaluru, Karnataka
-
Website
Looking for more details about Bandaram Pharma Packtech Ltd.’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
FAQs for Bandaram Pharma
What is the current share price of Bandaram Pharma Packtech Ltd Today?
The share price of Bandaram Pharma Packtech Ltd is ₹28.70 (BSE) as of 16-Jun-2026 IST. Bandaram Pharma Packtech Ltd has given a return of 2.5% in the last 3 years.
What is the current PB & PE ratio of Bandaram Pharma Packtech Ltd?
The P/E ratio of Bandaram Pharma Packtech Ltd is 115.13 times as on 16-Jun-2026, a 441 premium to its peers’ median range of 21.27 times.
The P/B ratio of Bandaram Pharma Packtech Ltd is 1.93 times as on 16-Jun-2026, a 114 premium to its peers’ median range of 0.90 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
101.80
|
4.40
|
|
2024
|
85.33
|
3.62
|
|
2023
|
29.56
|
7.13
|
|
2022
|
0.00
|
0.00
|
|
2021
|
0.00
|
0.00
|
What is the 52 Week High and Low of Bandaram Pharma Packtech Ltd?
The 52-week high and low of Bandaram Pharma Packtech Ltd are Rs 49.70 and Rs 22.00 as of 16-Jun-2026.
What is the market cap of Bandaram Pharma Packtech Ltd?
Bandaram Pharma Packtech Ltd has a market capitalisation of ₹ 52 Cr as on 16-Jun-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Bandaram Pharma Packtech Ltd?
Before investing in Bandaram Pharma Packtech Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.